XHKG
2591
Oct 28, Last price
3.27
1D
2.51%
1Q
-54.01%
IPO
-93.78%
Name
Guangzhou Innogen Pharmaceutical Group Co Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
92.33%
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
128m
Net income
-333m
CFO
-296m
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based investment holding firm with a core mission to research, develop, and bring to market medicinal products. The company specializes in producing innovative, human-compatible, and extended-duration GLP-1 receptor agonists, specifically targeting the treatment of diabetes and other metabolic conditions.
Key people
Wenjie Xu
Senior Vice President, Deputy General Manager, Executive Director · since 2024
Bing Huang
Vice President, Executive Director · since 2024
Jin Jin
Joint Company Secretary · since 2024
Suet Ling Sze
Joint Company Secretary · since 2024
Non-Executive Director · since 2024
Kyung Shik Ho
Non-Executive Director · since 2024
Heung Wing Chan
Independent Non-executive Directors · since 2025
Ruilin Song
Independent Non-executive Directors · since 2024
Wuping Tao
Independent Non-executive Directors · since 2022
Pui Fonk Yee
Independent Non-Executive Director · since 2024
Valuation
Title in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT |